Top

Published in:

01-12-2011 | Research

TWIST1 Promoter Methylation in Primary Colorectal Carcinoma

Authors: Rúbia D. Ruppenthal, Carmela Nicolini, Antonio Fabiano Ferreira Filho, Rosalva Meurer, Andréa P. Damin, Adriana Rohe, Cláudio O. P. Alexandre, Daniel C. Damin

Published in: Pathology & Oncology Research | Issue 4/2011

Abstract

TWIST1 gene, a transcription factor that belongs to the family of basic helix–loop–helix proteins, has been related to tumor progression and metastasis in different cancers. The aim of our study was to investigate TWIST1 promoter methylation in patients with primary colorectal carcinoma and determine its correlation with prognostic factors and disease outcome. Seventy-three patients with primary colorectal adenocarcinoma were studied. From each patient two tissue samples were collected: one sample of the tumor and one sample of normal colorectal tissue from an area located 15 cm away from the tumor. Samples of colorectal mucosa obtained from 30 individuals without malignant disease were also studied as a control group. All tissues were analyzed through methylation-specific PCR. TWIST1 hypermethylation was detected in colorectal specimens of 46 patients with cancer, but in none of the tissues from the nonmalignant control group (p < 0.001). In cancer patients, TWIST1 hypermethylation was found in 38 of 73 tumor samples as compared with 20 of 73 matched samples of non-cancerous colorectal tissue (P = 0.001). TWIST1 hypermethylation was not correlated with prognostic predictors for the disease outcome, patients’ overall survival and disease-free survival rates. We concluded that TWIST1 hypermethylation is present in the colon and rectum of most patients with colorectal carcinoma, suggesting this molecular alteration may be involved in the process of colorectal carcinogenesis.

Issa JP (2000) The epigenetics of colorectal cancer. Ann N Y Acad Sci 910:140–153PubMedCrossRef

Lee S, Hwang KS, Lee HJ et al (2004) Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia. Lab Invest 84:884–893PubMedCrossRef

Toyota M, Ahuja N, Ohe-Toyota M et al (1999) CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96:8681–8686PubMedCrossRef

Weisenberger DJ, Siegmund KD, Campan M et al (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38:787–793PubMedCrossRef

Teodoridis JM, Hardie C, Brown R (2008) CpG island methylator phenotype (CIMP) in cancer: causes and implications. Cancer Lett 268:177–186PubMedCrossRef

Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767PubMedCrossRef

Feinberg AP, Ohlsson R, Henikoff S (2006) The epigenetic progenitor origin of human cancer. Nat Rev Genet 7:21–33PubMedCrossRef

Fackler MJ, McVeigh M, Evron E et al (2003) DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and TWIST in situ and invasive lobular breast carcinoma. Int J Cancer 107:970–975PubMedCrossRef

Gort EH, Suijkerbuijk KP, Roothaan SM et al (2008) Methylation of the TWIST1 promoter, TWIST1 mRNA levels, and immunohistochemical expression of TWIST1 in breast cancer. Cancer Epidemiol Biomarkers Prev 17:3325–3330PubMedCrossRef

10.

Kwok WK, Ling MT, Lee TW et al (2005) Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res 65:5153–5162PubMedCrossRef

11.

Füchtbauer EM (1995) Expression of M-TWIST during postimplantation development of the mouse. Dev Dyn 204:316–322PubMedCrossRef

12.

Maestro R, Dei Tos AP, Hamamori Y et al (1999) TWIST is a potential oncogene that inhibits apoptosis. Genes Dev 13:2207–2217PubMedCrossRef

13.

Mironchik Y, Winnard PT Jr, Vesuna F et al (2005) TWIST1 overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. Cancer Res 65:10801–10809PubMedCrossRef

14.

Elias MC, Tozer KR, Silber JR et al (2005) TWIST1 is expressed in human gliomas and promotes invasion. Neoplasia 7:824–837PubMedCrossRef

15.

Valdés-Mora F, Gómez del Pulgar T, Bandrés E et al (2009) TWIST1 overexpression is associated with nodal invasion and male sex in primary colorectal cancer. Ann Surg Oncol 16:78–87PubMedCrossRef

16.

Kyo S, Sakaguchi J, Ohno S et al (2006) High TWIST1 expression is involved in infiltrative endometrial cancer and affects patient survival. Hum Pathol 37:431–438PubMedCrossRef

17.

Vesuna F, van Diest P, Chen JH, Raman V (2008) Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun 367:235–241PubMedCrossRef

18.

Rosivatz E, Becker I, Specht K et al (2002) Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and TWIST1 in gastric cancer. Am J Pathol 161:1881–1891PubMedCrossRef

19.

Yan-Qi Z, Xue-Yan G, Shuang H et al (2007) Expression and significance of TWIST basic helix-loop-helix protein over-expression in gastric cancer. Pathology 39:470–475PubMedCrossRef

20.

Yuen HF, Chan YP, Wong ML et al (2007) Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis. J Clin Pathol 60:510–514PubMedCrossRef

21.

Ohuchida K, Mizumoto K, Ohhashi S et al (2007) Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice. Int J Cancer 120:1634–1640PubMedCrossRef

22.

American Joint Committee on Cancer (AJCC) (1988) Manual for staging of cancer, 3rd edn. Lippincott, Philadelphia

23.

Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93:9821–9826PubMedCrossRef

24.

Leslie A, Carey FA, Pratt NR, Steele RJ (2002) The colorectal adenoma-carcinoma sequence. Br J Surg 89:845–860PubMedCrossRef

25.

Peltomäki P (2001) Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 10:735–740PubMedCrossRef

26.

Baylin SB, Ohm JE (2006) Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6:107–116PubMedCrossRef

27.

Frigola J, Solé X, Paz MF et al (2005) Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer. Hum Mol Genet 14:319–326PubMedCrossRef

28.

Yang J, Mani SA, Donaher JL et al (2004) TWIST1, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117:927–939PubMedCrossRef

29.

Yang J, Mani SA, Weinberg RA (2006) Exploring a new TWIST1 on tumor metastasis. Cancer Res 66:4549–4552PubMedCrossRef

30.

Okada T, Suheiro Y, Ueno K et al (2010) TWIST1 hypermethylation is observed frequently in colorectal tumors and its overexpression is associated with unfavorable outcomes in patients with colorectal cancer. Genes Chromosomes Cancer 49:452–462PubMed

31.

Martin TA, Goyal A, Watkins G, Jiang WG (2005) Expression of the transcription factors snail, slug, and TWIST1 and their clinical significance in human breast cancer. Ann Surg Oncol 12:488–496PubMedCrossRef

Title: TWIST1 Promoter Methylation in Primary Colorectal Carcinoma
Authors: Rúbia D. Ruppenthal
Carmela Nicolini
Antonio Fabiano Ferreira Filho
Rosalva Meurer
Andréa P. Damin
Adriana Rohe
Cláudio O. P. Alexandre
Daniel C. Damin
Publication date: 01-12-2011
Publisher: Springer Netherlands
Published in: Pathology & Oncology Research / Issue 4/2011
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI: https://doi.org/10.1007/s12253-011-9395-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2011

Entire-volume Serial Histological Examination for Detection of Micrometastases in Lymph Nodes of Colorectal Cancers

Higher Serum DPP-4 Enzyme Activity and Decreased Lymphocyte CD26 Expression in Type 1 Diabetes

Down-Regulated miRNA-214 Induces a Cell Cycle G1 Arrest in Gastric Cancer Cells by Up-Regulating the PTEN Protein

High Frequency of Genes’ Promoter Methylation, but Lack of BRAF V600E Mutation among Iranian Colorectal Cancer Patients

Molecular Cytogenetic Characterization in Four Pediatric Pheochromocytomas and Paragangliomas

Chemotherapy Response Analysis for Osteosarcom with Intra-arterial Chemotherapy by Subcutaneous Implantable Delivery System

Keynote webinar | Spotlight on antibody–drug conjugates in cancer